华夏时报记者李佳佳李未来北京报道 当前，焦炭上下游开工率比较高。从供应端来看，据Mysteel统计，上周523家炼焦煤矿山样本核定产能利用率为82.7%，环比提高6.9%。原煤日均产量 185.6万吨，精煤日均产量72.8万吨，后者环比增加3.5万吨。 杨婷告诉记者，独立焦企产能利用率回升，全样本焦炭日均产量环比略增，企业没有开始主动控产，且主动控产的意愿不强。焦化厂产能利用率同步回 升，削弱了下游钢厂的原料采购意愿。 近日，主流钢厂正式落地焦炭第二轮调价，具体来看，湿熄焦价格每吨下调50元，干熄焦价格每吨下调55元。据统计，两轮调价中单轮跌幅均维持在50 元/吨左右，截至目前，湿熄焦累计跌幅已达100元/吨，干熄焦累计跌幅则略高于这一水平。 上海钢联（300226）煤焦事业部焦炭分析师杨婷向《华夏时报》记者分析表示，焦炭价格连续两轮降价主要源于两方面因素：一是钢厂因成材销售疲软， 利润受到挤压，所以向上游寻求利润；二是焦煤价格下跌，给焦炭带来的价格支撑走弱。 一德期货天津分公司高级分析师张源指出，前期，市场大多预计焦炭价格将下降三轮左右，累计下调约150元/吨。不过，受近两天盘面情绪好转，叠加临 近国庆现货 ...

Group 1 - Vanke Group has officially updated its organizational structure, marking a significant transformation in its management approach, with the previous regional companies being replaced by 16 city companies directly managed by the headquarters [2][3] - The restructuring aims to optimize operational efficiency by focusing on eight business divisions, including property management, commercial and hotel operations, long-term rental apartments, and logistics, moving away from a regional-centric management style [2][3] - The changes reflect a strategic repositioning under the influence of Shenzhen Metro Group, which has taken a more active role in Vanke's management and governance since acquiring a significant stake in the company [4][5] Group 2 - The restructuring is seen as a response to the need for operational stability and transformation, following a series of leadership changes and the introduction of Shenzhen Metro executives into key positions [5][6] - The new management structure emphasizes a flatter hierarchy, consolidating functions such as procurement, finance, and human resources under centralized control, while regional companies are redefined as execution platforms [6][9] - Vanke's previous regional management model has been criticized for inefficiencies, prompting the need for a more streamlined approach to enhance decision-making and risk management [9][10] Group 3 - Vanke has divested a significant portion of its snow business to Hong Kong Travel, indicating a strategic shift to focus on its core real estate operations and improve financial health [11][12] - The decision to exit the snow business is part of a broader strategy to streamline operations and reduce debt, as the company faces ongoing financial challenges, including a reported loss of 11.947 billion yuan in the first half of 2025 [15] - The divestiture reflects a recognition that the snow business, which has been marginalized within the company's portfolio, does not align with Vanke's traditional strengths and operational focus [13][14]

Core Insights - The article discusses the launch of NanoForge, the world's first AI-driven nanomedicine delivery platform developed by JiTai Technology, which aims to revolutionize targeted drug delivery systems in the biopharmaceutical industry [2][3][4]. Company Overview - JiTai Technology is a biotech company focused on AI-driven innovations in nanomaterials, boasting over 10 million lipid structures and 100,000 data points for model training [3][4]. - The company has developed over 10 pipeline projects, with 7 preclinical candidates and 4 clinical projects, the fastest of which has reached the pre-NDA stage [3][4]. Technology and Innovation - NanoForge integrates quantum chemistry and molecular dynamics simulations with proprietary high-throughput wet lab experiments, enabling a closed-loop process from molecular generation to formulation optimization [2][4]. - The platform includes three core solutions: AiLNP (AI nucleic acid delivery system design), AiRNA (AI mRNA sequence design), and AiTEM (AI small molecule formulation design) [2][3]. Market Potential - The global nanomedicine market is projected to reach $580 billion within the next decade, positioning JiTai Technology to capitalize on this growth [6]. - The company aims to overcome existing patent barriers and expand organ-specific targeting capabilities through its innovative platform [6]. Clinical Breakthroughs - JiTai Technology has achieved significant advancements in targeted delivery systems, with liver-targeting LNPs demonstrating delivery efficiency exceeding clinical benchmarks by 20 times [9]. - The platform has shown promise in delivering nucleic acid drugs to various tissues, including the heart and lungs, potentially addressing previously untreatable genetic and autoimmune diseases [10][12]. Strategic Partnerships and Funding - The company has attracted over $300 million in investments from major firms like CICC and Sequoia, and is collaborating with top pharmaceutical companies [14]. - JiTai Technology's operational model is designed to significantly reduce the time required for lipid development and clinical candidate progression, aiming to compress timelines from years to months [14]. Future Outlook - The launch of NanoForge marks a paradigm shift in drug development, emphasizing design over discovery and expanding the scope of treatment to include reprogramming biological processes [14]. - JiTai Technology's innovative approach is set to initiate a competitive landscape in the drug delivery sector, with the potential to transform the treatment landscape for patients with previously deemed untreatable conditions [14].

2025年9月18日凌晨，美联储公布议息会议结果，将联邦基金利率目标区间下调25个基点至4.00%– 4.25%，符合市场广泛预期。 本报（chinatimes.net.cn）记者帅可聪 北京报道 当天早盘，A股三大指数小幅震荡走强，上证指数盘中一度逼近3900点关口。截至午间收盘，上证指数 涨0.45%，报3893.95点；深证成指涨0.79%，报13319.7点；创业板指涨0.49%，报3162.9点。 前海开源基金首席经济学家杨德龙向《华夏时报》记者表示，美联储降息可能会引发全球央行降息潮， 中国央行有较大的货币政策宽松的空间，有望通过降息降准来提振经济，稳住楼市股市。这对于当前已 经开启一轮牛市的资本市场会形成利好推动。 粤开证券首席经济学家、研究院院长罗志恒分析称，美联储降息对中国股市、债市和人民币汇率偏利 好。全球流动性宽松有助于为中国股市提供增量资金，中国货币政策空间增大将带动债券收益率下行， 美元承压有利于人民币汇率稳定。 预计年内还有两次降息 这是美联储自2024年12月以来时隔9个月重启降息，25个基点的降息幅度符合市场普遍预期。 罗志恒认为，美联储此次重启降息周期有助于托底需求与就业，但 ...

Core Viewpoint - Haili Biological has adjusted the acquisition price of 55% equity in Ruisheng Biological from 935 million yuan to 536 million yuan due to industry policy changes and intensified market competition, aiming to mitigate goodwill impairment risks [2][5][6]. Company Summary - Haili Biological completed the acquisition of Ruisheng Biological in October 2024, marking a significant business transformation into the oral repair materials sector [2]. - The acquisition price was initially set at 935 million yuan, but was later reduced to 536 million yuan, with a difference of approximately 399 million yuan to be refunded by Meilun Management [5][6]. - The adjustment reflects a decrease in Ruisheng Biological's valuation from 1.711 billion yuan to 974 million yuan, resulting in a significant reduction in goodwill [5][6]. - Haili Biological still holds 55% of Ruisheng Biological after the price adjustment, which is expected to positively impact cash flow [2][6]. Industry Summary - Ruisheng Biological specializes in human tissue repair and regenerative medical products, including oral bone graft materials and absorbable membranes [3]. - The market has seen an influx of new competitors, leading to price wars that have negatively impacted Ruisheng Biological's product pricing, with a nearly 30% decrease in prices compared to Q1 2024 and a further 40% drop in Q2 2025 [4][9]. - The tightening of tax incentives has also adversely affected Ruisheng Biological's revenue and profit margins, as the company shifted from a simplified tax rate of 3% to a general tax rate of 13% [5]. - Despite the challenges, Haili Biological anticipates long-term growth in the oral repair materials market driven by aging populations and increasing demand for dental implants [9][10].

Core Insights - The new CEO Huang Zhipan emphasizes a pragmatic approach to development, focusing on product quality and customer loyalty rather than aggressive market positioning [2][6] - The company aims to establish a complete smart ecosystem centered around "mobile phones + XR + smart cars" [7][9] Product Launch and Market Strategy - The flagship product, Meizu 22, was delayed for over a year, with the company acknowledging the challenges faced during its development [3][5] - Meizu 22 features four 50MP cameras and is priced at 2999 yuan, lower than the previous model's starting price of 3399 yuan, indicating a strategy to attract price-sensitive consumers [5][6] - The company is also focusing on low-cost AI phones to capture market share in the competitive mid-to-low-end market [6] XR and Smart Car Initiatives - The company launched the StarV Snap AI glasses, priced at 1999 yuan, which integrates payment functions and aims to create new market scenarios through partnerships with Alipay [7] - The Flyme Auto system has been integrated into 28 vehicle models, with over 1.5 million users, showcasing the company's commitment to building a comprehensive application ecosystem [9] Market Position and Future Outlook - Despite ambitious goals to return to the top five in the domestic mid-to-high-end smartphone market, the company acknowledges the challenges posed by stronger competitors [6][8] - The company is taking a cautious approach to growth, focusing on product excellence and sustainable development rather than rapid expansion [9]

本报（chinatimes.net.cn）记者卢晓 北京报道 进入AI时代，云计算厂商普遍被打了一剂强心针。不过它们还想获得更多增长。 9月16日，腾讯云宣布正式发布智能体战略全景图，全面开放AI能力、C端和B端优势场景。"向智能化 要产业效率，向全球化要收入规模，已经成为企业增长的两大核心动力，也是影响未来行业格局的关 键。"9月16日，腾讯集团高级执行副总裁、云与智慧产业事业群CEO汤道生在腾讯全球数字生态大会上 这样说。 不过所有云计算厂商显然都不想错过这场由AI和出海共同带来的集体普涨，B端市场的竞争已经越发激 烈。 To B营收双位数增长背后 9月16日，腾讯云发布了多项AI技术产品与最新升级，其中腾讯云智能体开发平台（ADP）面向全球发 布3.0版。据悉，面对产业实战中的智能体需求，ADP在3个月内完成了近600项需求的开发，持续迭代 了LLM+RAG、Workflow、Multi-Agent等多种智能体开发框架。 不过吴运声同时也表示，AI智能体真正落地时面临的是一系列系统性问题，需要逐步解决，"智能体及 智能体开发平台不是半年、一年就能做好的短期项目，而是需要三五年甚至十年持续投入的长期事 业 ...

Core Viewpoint - The Ministry of Commerce and nine other departments have issued a notification to promote service consumption, proposing 19 specific measures to boost consumption and expand domestic demand [2][3] Group 1: Policy Measures - The notification includes plans to develop pilot cities for new consumption formats, models, and scenarios, aiming to enhance consumption supply and innovate diverse consumption experiences [2] - Approximately 50 pilot cities will be selected based on competitive evaluation, focusing on those with large populations, strong driving effects, and good development potential [2][3] Group 2: Consumer Demand Trends - There is a shift in consumer demand from quantity to quality, with increasing expectations for high-quality, personalized, and experiential consumption [3] - Different demographic groups have specific consumption needs, such as the younger generation seeking experiential lifestyles and the elderly desiring enjoyable and secure living conditions [3] Group 3: Economic Impact - New consumption formats and scenarios are expected to have strong radiating and cross-regional effects, promoting the development of related industries such as culture, tourism, transportation, and accommodation [3] - The pilot cities will leverage innovation in consumption scenarios and model iterations to drive regional consumption resource integration, creating a model of "one innovation leading to multi-regional linkage" [3]

Core Insights - The Chinese commercial vehicle market is undergoing a significant transformation driven by both policy and market demand, with a notable increase in the penetration rate of new energy commercial vehicles to 27.6% in August 2025, reflecting a 0.8 percentage point increase from the previous month [1] - BYD's strategy of "technology as a spear" is becoming increasingly clear, as evidenced by the launch of the e-Bus platform 3.0 and the new electric bus C11, which features a groundbreaking 1000V high-voltage platform and improvements in energy consumption and low-temperature range [1][5] - The release of the e-Bus platform 3.0 is seen as a pivotal moment in the transition of the commercial vehicle industry from being policy-driven to technology-driven [1][5] Market Dynamics - The commercial vehicle market in 2025 shows a clear structural differentiation, with heavy truck sales increasing by 46.7% year-on-year in August, while medium and light trucks experienced declines of 9.3% and 14.8%, respectively [2] - The overall bus market grew by 11.6%, but the growth rate for medium and large buses (9.2%) lagged behind that of light buses (12.4%), indicating a strong demand for efficient and environmentally friendly commercial vehicles [2] - The domestic market for new energy commercial vehicles saw a significant increase in sales, with a 58.6% growth rate, while export growth was only 9.5%, highlighting the stringent requirements of international markets for technological reliability [2] Technological Advancements - BYD has invested over 14 billion yuan in new energy commercial vehicle research and development since 2008, employing more than 7,000 R&D personnel, establishing itself as a leader in the field [3] - The e-Bus platform 3.0 represents a technological breakthrough that sets new industry standards, particularly with its 1000V high-voltage architecture, which addresses current concerns regarding range anxiety and energy consumption [5] - Innovations in safety technology and intelligent systems are redefining bus safety standards and enhancing operational efficiency, thereby improving user experience and market confidence in electric buses [5][6] Future Outlook - The launch of the new platform aligns with the accelerating trend towards new energy commercial vehicles, with expectations of a sales peak during the "golden September and silver October" period [6] - BYD's position as a leader in new energy bus exports, with a presence in over 70 countries and regions, is expected to strengthen its international competitiveness and contribute to the global standing of Chinese manufacturing [6][7] - The e-Bus platform 3.0 is viewed as a milestone that injects strong momentum into the global electric bus market, promoting a shift towards greener and smarter commercial vehicles [7]

Core Viewpoint - The appointment of Huang Deliang as the new chairman of Xingyin Fund marks the end of a five-month leadership vacuum, but he faces significant challenges due to the company's heavy reliance on fixed-income products and recent fluctuations in asset management scale [2][4][9]. Group 1: Company Performance - Xingyin Fund's asset management scale peaked at 125.23 billion yuan at the end of 2023, driven by explosive growth in money market funds, but fell to 106.28 billion yuan by the end of 2024 and further declined to 87.16 billion yuan in Q1 2025, marking its first drop below the 100 billion yuan threshold [4][5]. - By the end of Q2 2025, the scale slightly recovered to 103.58 billion yuan, ranking 53rd among 162 public fund companies, indicating significant volatility in its asset management scale [5][6]. Group 2: Business Structure - As of September 16, 2025, Xingyin Fund's total managed assets were approximately 111.5 billion yuan, with bond funds accounting for 66.57 billion yuan (59.69%) and money market funds for 39.94 billion yuan (35.82%), together comprising over 95% of the company's business [7]. - The company has a pronounced "debt-heavy" structure, with equity and mixed funds only amounting to 2.34% and 1.12% of total assets, respectively, highlighting a severe dependency on fixed-income products [7]. Group 3: Management Changes - Xingyin Fund has experienced frequent management changes, with multiple general managers replaced since 2021, culminating in the recent appointment of Huang Deliang as chairman and the restructuring of the board [8][9]. - Huang Deliang's extensive background in the financial sector, particularly in promoting a "commercial bank + investment bank" model, may provide new opportunities for business transformation within the fund [9][10].